Redefining resectability in pancreatic cancer after neoadjuvant therapy: are we any closer?

Hepatobiliary Surg Nutr. 2023 Feb 28;12(1):131-134. doi: 10.21037/hbsn-22-638. Epub 2023 Jan 16.

Authors

Francis P Robertson^{1

2}, Sanjay Pandanaboyana^{1

3}

Affiliations

¹ Department of HPB and Transplant Surgery, Newcastle Upon Tyne NHS Foundation Trust, Freeman Hospital, Newcastle Upon Tyne, UK.
² Division of Surgery and Interventional Science, University College London, Royal Free Campus, London, UK.
³ Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.

No abstract available

Keywords: Pancreatic cancer; neoadjuvant therapy (NAT); resectability.

Publication types

Editorial
Comment